Lessons learned from BRCA1 and BRCA2

被引:131
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [41] Clinical significance of large rearrangements in BRCA1 and BRCA2
    Judkins, Thaddeus
    Rosenthal, Eric
    Arnell, Christopher
    Burbidge, Lynn Anne
    Geary, Wade
    Barrus, Toby
    Schoenberger, Jeremy
    Trost, Jeffrey
    Wenstrup, Richard J.
    Roa, Benjamin B.
    CANCER, 2012, 118 (21) : 5210 - 5216
  • [42] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261
  • [43] Refining BRCA1 and BRCA2 penetrance estimates in the clinic
    Susan M. Domchek
    Current Breast Cancer Reports, 2009, 1 (3) : 127 - 130
  • [44] Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer
    Antunes Meireles, Pedro
    Fragoso, Sofia
    Duarte, Teresa
    Santos, Sidonia
    Bexiga, Catarina
    Nejo, Priscila
    Luis, Ana
    Mira, Beatriz
    Miguel, Isalia
    Rodrigues, Paula
    Vaz, Fatima
    CANCERS, 2023, 15 (23)
  • [45] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Jane C. Figueiredo
    Jennifer D. Brooks
    David V. Conti
    Jenny N. Poynter
    Sharon N. Teraoka
    Kathleen E. Malone
    Leslie Bernstein
    Won D. Lee
    David J. Duggan
    Ashley Siniard
    Patrick Concannon
    Marinela Capanu
    Charles F. Lynch
    Jørgen H. Olsen
    Robert W. Haile
    Jonine L. Bernstein
    Breast Cancer Research and Treatment, 2011, 127 : 819 - 829
  • [46] An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
    Georgia Chenevix-Trench
    Roger L Milne
    Antonis C Antoniou
    Fergus J Couch
    Douglas F Easton
    David E Goldgar
    Breast Cancer Research, 9
  • [47] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Figueiredo, Jane C.
    Brooks, Jennifer D.
    Conti, David V.
    Poynter, Jenny N.
    Teraoka, Sharon N.
    Malone, Kathleen E.
    Bernstein, Leslie
    Lee, Won D.
    Duggan, David J.
    Siniard, Ashley
    Concannon, Patrick
    Capanu, Marinela
    Lynch, Charles F.
    Olsen, Jorgen H.
    Haile, Robert W.
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 819 - 829
  • [48] BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia
    El-Harith, EHA
    Abdel-Hadi, MS
    Steinmann, D
    Dork, T
    SAUDI MEDICAL JOURNAL, 2002, 23 (06) : 700 - 704
  • [49] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Gomes, Magda C. B.
    Costa, Mauricio M.
    Borojevic, Radovan
    Monteiro, Alvaro N. A.
    Vieira, Roberto
    Koifman, Sergio
    Koifman, Rosalina Jorge
    Li, Song
    Royer, Robert
    Zhang, Shiyu
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 349 - 353
  • [50] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba
    Rodriguez, Rolando Comacho
    Esperon, Antonio Alejandro
    Ropero, Ramon
    Rubio, Maria Caridad
    Rodriguez, Ronald
    Ortiz, Rosa M.
    Anta, Juan J. Lence
    de los Rios, Mario
    Carnesolta, Deyanira
    del Olivera, Maria C.
    Vansam, Somalia Stiu
    Royer, Robert
    Akbari, Mohammad R.
    Donenberg, Talia
    Narod, Steven A.
    FAMILIAL CANCER, 2008, 7 (03) : 275 - 279